CLINICAL_TRIALS ClinicalTrials.gov record update

Individual Albuminuria Lowering Response to Dapagliflozin in a Decentralized Clinical Trial in Patients With Type 2 Diabetes Mellitus and Elevated Albuminuria

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06374043
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:49.240201+00:00
Published At: 2024-04-22T00:00:00+00:00
Record Updated At: 2024-04-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diabetes Mellitus, Type 2", "Diabetes Mellitus Type 2 With Proteinuria", "Diabetes Mellitus", "Diabetes", "Diabetes Complications", "Albuminuria", "Chronic Kidney Diseases", "Chronic Kidney Disease Due to Type 2 Diabetes Mellitus", "CKD", "Proteinuria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-04-22"
protocolSection.identificationModule.nctId: "NCT06374043"
protocolSection.identificationModule.officialTitle: "Individual Albuminuria Lowering Response to Dapagliflozin in a Decentralized Clinical Trial in Patients With Type 2 Diabetes Mellitus and Elevated Albuminuria"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.